BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
BTX.WS was delisted on the 26th of September, 2018.
39 hedge funds and large institutions have $963K invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
3% less funds holding
Funds holding: 40 → 39 (-1)
50% less capital invested
Capital invested by funds: $1.94M → $963K (-$980K)
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.21K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$68 |
| 3 |
CTC
Central Trust Company
Jefferson City,
Missouri
|
+$34 |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$30.8K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$2.48K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$2K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.3K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$1.07K |
BTX.WS Hedge Fund Activity: Q1 2016 in Review
39 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q1 2016, worth a combined $963K — down 50% from $1.94M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BTX.WS positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 9 trimmed.
The largest buyer was UBS Group, adding an estimated $1.21K. The largest seller was Ionic Capital Management, cutting an estimated $30.8K.
- 39 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q1 2016, down from 40 in Q4 2015.
- Funds reported $963K of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q1 2016, down 50% quarter-over-quarter.
- 2 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q1 2016 and 1 closed out, a net change of +1 holder.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q1 2016 was UBS Group, an estimated $1.21K added.
- The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q1 2016 was Ionic Capital Management, an estimated $30.8K sold.
Based on aggregated 13F filings for Q1 2016.